🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, open-label, multicenter, dose-escalation \& expansion st...
Status
Unknown
Location
The First Affiliated Hospital of Nanchang University
Start Date
2023-02-14
Trial ID
NCT05641259
Treatments Being Tested
The investigator is testing the addition of venetoclax to 5-azacitidine and...
Status
Recruiting
Location
Children's Wisconsin
Start Date
2023-03-31
Trial ID
NCT05317403
Treatments Being Tested
This is a dose escalation followed by dose expansion study of TL32711 in co...
Status
Completed
Location
Palo Verde Hematology Oncology
Start Date
2013-06
Trial ID
NCT01828346
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
U.T.M.D. Anderson Cancer Center
Start Date
2005-12
Trial ID
NCT00569010
Treatments Being Tested
Patients are being asked to take part in this study because they have metas...
Status
Terminated
Location
Emory University Winship Cancer Institute
Start Date
2010-07
Trial ID
NCT01194908
Treatments Being Tested
This is a pilot study using decitabine and vorinostat before and during che...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2017-07-11
Trial ID
NCT03263936
Treatments Being Tested
The main part of this trial is a phase II study of vosaroxin with azacitidi...
Status
Completed
Location
Kliniken Essen-Süd, Evang. Krankenhaus Essen-Werden gGmbH
Start Date
2018-04-19
Trial ID
NCT03338348
Treatments Being Tested
This is a phase I study with a primary objective of determining the recomme...
Status
Recruiting
Location
Froedtert Hospital & the Medical College of Wisconsin
Start Date
2025-01-10
Trial ID
NCT06502145
The purpose of this research study is to test the safety of a new three dru...
Status
Active Not Recruiting
Location
Brigham and Women's Hospital
Start Date
2022-07-18
Trial ID
NCT05455294
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of iadadem...
Status
Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2024-08-22
Trial ID
NCT06357182